The Prognostic Effect of Dexamethasone on Patients With Glioblastoma: A Systematic Review and Meta-Analysis

Background: Dexamethasone (DEX) is widely adopted to reduce tumor-associated edema in glioblastoma (GBM) patients despite its side effects. However, the benefits of using DEX in GBM patients remains elusive. Methods: In this study, we performed a comprehensive meta-analysis to address this concern....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Lingling, Shen, Yang, Huang, Tingting, Sun, Yangyang, Alolga, Raphael N., Zhang, Gang, Ge, Yuqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438116/
https://www.ncbi.nlm.nih.gov/pubmed/34531751
http://dx.doi.org/10.3389/fphar.2021.727707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438116/
https://www.ncbi.nlm.nih.gov/pubmed/34531751
http://dx.doi.org/10.3389/fphar.2021.727707

Ejemplares similares